AI assistant
Sending…
RIGEL PHARMACEUTICALS INC — Director's Dealing 2008
May 31, 2008
32801_dirs_2008-05-30_de4cb11f-0986-431e-93bd-4c57ac5a717a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2008-05-30
Reporting Person: DELEAGE JEAN (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-05-30 | Stock Option (Right to Buy) | $23.10 | A | 10000 | Acquired | 2018-05-30 | Common Stock (10000) | Direct |
Footnotes
F1: Ths shares shall vest monthly over twelve (12) months from the date of grant.
More from RIGEL PHARMACEUTICALS INC
Regulatory Filings
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 3
Annual Report
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19